A biochemical basis for the actions of lithium on behaviour and on immunity: relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic-depression of the immune system.
D015126:8,11,14-Eicosatrienoic Acid / Q000378:metabolism; D001714:Bipolar Disorder / Q000188:drug therapy*; D003078:Colchicine / Q000494:pharmacology; D003863:Depression / Q000188:drug therapy; D006402:Hematologic Diseases / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000150:complications*; D006801:Humans; D007109:Immunity / Q000187:drug effects; D008094:Lithium / Q000494:pharmacology / Q000627:therapeutic use*; D008954:Models, Biological; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000378:metabolism; D009753:Nutritive Value; D011458:Prostaglandins E / Q000037:antagonists & inhibitors; D012008:Recurrence; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects
D008996:Monoamine Oxidase Inhibitors; D011458:Prostaglandins E; D008094:Lithium; D015126:8,11,14-Eicosatrienoic Acid; D003078:Colchicine